Published guidance, NICE advice and quality standards

Showing 231 to 240 of 1866

Sort by

Published guidance, NICE advice and quality standards
Title	Reference number	Published	Last updated
Brentuximab vedotin in combination for untreated systemic anaplastic large cell lymphoma	TA641	12 August 2020	12 August 2020
Brexucabtagene autoleucel for treating relapsed or refractory B-cell acute lymphoblastic leukaemia in people 26 years and over	TA893	7 June 2023	7 June 2023
Brexucabtagene autoleucel for treating relapsed or refractory mantle cell lymphoma	TA677	24 February 2021	24 February 2021
Brigatinib for ALK-positive advanced non-small-cell lung cancer that has not been previously treated with an ALK inhibitor	TA670	27 January 2021	27 January 2021
Brigatinib for treating ALK-positive advanced non-small-cell lung cancer after crizotinib	TA571	20 March 2019	20 March 2019
Brodalumab for treating moderate to severe plaque psoriasis	TA511	21 March 2018	21 March 2018
Brolucizumab for treating diabetic macular oedema	TA820	31 August 2022	31 August 2022
Brolucizumab for treating wet age-related macular degeneration	TA672	3 February 2021	3 February 2021
Bronchial thermoplasty for severe asthma	IPG635	19 December 2018	19 December 2018
Bronchiectasis (non-cystic fibrosis), acute exacerbation: antimicrobial prescribing	NG117	18 December 2018	18 December 2018